Antimicrobial resistance (AMR) occurs naturally over time, usually through genetic changes. However, the misuse and overuse of antibiotics is accelerating this process. AMR is putting the gains of the Millennium Development Goals at risk and endangers achievement of the Sustainable Development Goals.
In order to fight against this threat, NeoGiANT will develop novel natural antimicrobial products for the control and prevention of the most relevant diseases in animal production based on natural extracts derived from agri-food byproducts as raw materials. The use of these alternative products will relegate antibiotics only to the treatment of acute infections and reducing their current prophylactic use.
These new products, based on natural extracts, using an advanced isolation technique, will not only avoid the growth of microorganisms but also improve the health and welfare of the animals, increasing profitability.
This project is based on the use of biomass sources (white grape marc) that can provide cost-effective, efficient and green solutions to obtain functional ingredients in sustainable circular economy production systems.
Our final applications
The main objective of NeoGiANT is to develop and validate innovative natural formulations with antimicrobial and antioxidant properties from the valorisation of white grape marc, to be used in cattle, swine, poultry and farmed fish production in the FEEDING, HEALTH and REPRODUCTION areas, aiming to reduce the dependence on the use of antibiotics in animal/aquaculture production.
Universidade de Santiago de Compostela
Moredun Research Institute
Prof. Waclaw Dabrowski Institute of Agriculture and Food Biotechnology State Research Institute
Veterinary Research Institute
Hungarian University of Agriculture and Life Sciences
Freie Universität Berlin
Universidade do Porto – Faculdade de Ciências
University of La Laguna
Asociación Española de normalización
University of South Bohemia
National Scientific and Technical Research Council
Asociación Agraria de Jóvenes Agricultores
Contactica Innovation S.L.